Carlsmed (CARL) Accumulated Expenses (2024 - 2026)

Carlsmed (CARL) has reported Accumulated Expenses for 3 consecutive years, with $4.1 million the latest figure, recorded in Q2 2026.

• For the quarter ending Q2 2026, Accumulated Expenses rose 27.77% year-over-year to $4.1 million; the trailing twelve-month figure through Jun 2026 stood at $4.1 million (up 27.77% YoY), and the FY2025 full-year result was $5.8 million, up 76.15% from the prior year.
• Accumulated Expenses climbed to $4.1 million in Q2 2026 per CARL's latest filing, from $3.2 million in the prior quarter.
• Across five years, Accumulated Expenses topped out at $5.8 million in Q4 2025 and bottomed at $3.2 million in Q1 2026.
• Historically, Accumulated Expenses has averaged $4.0 million across 3 years, with a median of $3.7 million in 2024.
• The sharpest annual moves came in 2025 and 2026: Accumulated Expenses soared 76.15% in 2025, then grew 27.77% in 2026.
• Over 3 years, Accumulated Expenses stood at $3.3 million in 2024, then jumped by 76.15% to $5.8 million in 2025, then declined by 28.59% to $4.1 million in 2026.
• According to Business Quant data, Accumulated Expenses over the past three periods registered $4.1 million, $3.2 million, and $5.8 million for Q2 2026, Q1 2026, and Q4 2025 respectively.